| Mr Matthew Webb, APRN, FNP-BC | |
|
3833 S Development Ave, Boise, ID 83705-5354 | |
| (208) 387-5280 | |
| Not Available |
| Full Name | Mr Matthew Webb |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 3833 S Development Ave, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467854109 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Matthew Webb, APRN, FNP-BC 3833 S Development Ave, Boise, ID 83705-5354 Ph: (208) 387-5280 | Mr Matthew Webb, APRN, FNP-BC 3833 S Development Ave, Boise, ID 83705-5354 Ph: (208) 387-5280 |
News Archive
Sinapis Pharma, Inc. has successfully completed a Bridge financing to continue to support its drug development program. Sinapis Pharma has discovered and is developing a novel therapeutic approach to neuronal protection using its intravenous methamphetamine technology. The company has strong pre-clinical data in stroke and traumatic brain injury animal models conclusively demonstrating a 12-hour therapeutic window and multiple pathway neuroprotection.
ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax platform, a novel depot vaccine delivery system used to increase the efficacy and strength of vaccines. IVT has filed additional patents to protect the DepoVax concept.
Children with broken bones or joint dislocations in northern Israel emergency departments received equal pain treatment, regardless of their ethnicity or the ethnicity of the nurses who treated them, even during a period of armed conflict between the two ethnic groups.
Decision Simulation LLC, the leading provider of web-based virtual patient platforms that enhance clinical decision-making skills, today announced it has extended its licensing agreement with the University of Pittsburgh.
Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.
› Verified 8 days ago
Nora M Suarez, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
Dr. Nancy Jane L'heureux, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6259 W Emerald St, Boise, ID 83704 Phone: 208-489-1900 Fax: 208-375-5286 | |
Jennifer Woodburn, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-5015 | |
Carl Ciplinski, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10583 W Lake Hazel Rd, Boise, ID 83709 Phone: 208-302-5950 | |
Kathryn Laura Cnossen, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8000 S Federal Way, Boise, ID 83716 Phone: 208-368-2109 | |
Mrs. Chelsea Rose Wallace, RN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9976 W Emerald St, Boise, ID 83704 Phone: 208-229-3742 | |
Natasha Michele King-anderson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 707 N Armstrong Pl, Boise, ID 83704 Phone: 208-375-5211 |